Skip to main content

Biofourmis

By Adam Ang | 03:43 am | October 18, 2024
Also, JLK and Heuron have received regulatory clearances for their medical imaging AI in the US and South Korea.
By Jessica Hagen | 09:25 pm | August 30, 2023
Kuldeep Singh Rajput's departure comes just one month after the company laid off 120 employees.
By Jessica Hagen | 12:21 pm | July 24, 2023
The company let go of 48 workers in the U.S.
By Emily Olsen | 01:33 pm | March 27, 2023
Dr. Maulik Majmudar, chief medical officer and cofounder of Biofourmis, discusses why healthcare often struggles to address the consumer experience.
By Bill Siwicki | 01:34 pm | August 22, 2022
A clinician shortage crisis is on the horizon. Here are some ideas from a top expert on what can be done.  
By Emily Olsen | 11:16 am | August 10, 2022
Also, Northwestern University spinout Sibel Health raises $33 million, and real-world evidence startup Atropos Health scoops up $14 million.
By Emily Olsen | 11:15 am | April 26, 2022
Coming nearly two years after the company's $100 million Series C, Biofourmis tallied its total raise at $445 million.
By Emily Olsen | 02:48 pm | February 09, 2022
Biofourmis Care currently includes programs for heart failure, hypertension, diabetes, lipid management and atrial fibrillation.
By HIMSS TV | 01:23 pm | May 25, 2021
Remote patient monitoring must become remote patient management, says Dr. Maulik Majmudar, who developed Halo at Amazon and now serves as chief medical officer at Biofourmis.
By MobiHealthNews | 04:18 pm | May 11, 2021
Also: Santosh Mohan leaves MassGen Brigham for Moffitt Cancer Center and Zipari names C-suite hires.